Cellectis has won U.S. regulatory approval to run an early clinical trial using its gene edited cell therapy product UCART123 for blood cancers, boosting the French biotech firm’s ambitions in the hot area of cancer research. More »
Mylan NV has agreed to pay $96.5 million to settle claims by drug purchasers that it delayed launching a generic version of Cephalon Inc’s narcolepsy drug Provigil in exchange for payment from Cephalon. More »
Express Scripts Holding Co, the largest pharmacy benefit manager in the United States, said prescription drug spending for its members slowed to less than 4 percent in 2016, at a time when scrutiny of drug price hikes has intensified. More »
Emma Walmsley of GlaxoSmithKline poses in this undated photograph released in London on September 20, 2016. Courtesy of GlaxoSmithKline/Handout via REUTERS Emma Walmsley, GlaxoSmithKline’s (GSK.L) incoming CEO, will take over Britain’s biggest drugmaker at a c... More »
Laboratory Corporation of America Holdings (LabCorp) is in talks to acquire contract researcher Pharmaceutical Product Development LLC (PPD) for more than $8 billion, including debt, people familiar with the matter said on Friday. More »
Novo Nordisk, the world’s top maker of diabetes drugs, is investing 115 million pounds ($145 million) in a new research center in Britain, undeterred by Brexit. More »
European prices for some off-patent cancer drugs have risen by more than 100 percent in the past five years, with two cases of hikes exceeding 1,000 percent, according to data presented at a medical conference on Saturday. More »
Two babies rescued from previously incurable leukemia after receiving infusions of gene-edited immune cells are doing well at home more than a year after initial treatment, scientists said on Wednesday. More »
Actelion’s Opsumit drug missed a primary endpoint in a late-stage study of patients with pulmonary arterial hypertension due to Eisenmenger Syndrome, a doctor involved in the trial said in a statement from the Swiss drugmaker. More »
Egypt’s military has received the license required to form a pharmaceutical company, a decree by Prime Minister Sherif Ismail published on Sunday showed. More »
U.S. President Donald Trump, flanked by Senior Advisor Jared Kushner (standing, L-R), Vice President Mike Pence and Staff Secretary Rob Porter welcomes reporters into the Oval Office for him to sign his first executive orders at the White House in Washington, ... More »
Merck & Co said it agreed to enter into a settlement and license agreement with Bristol-Myers Squibb Co and Ono Pharmaceutical Co Ltd to resolve all global patent-infringement litigation related to its cancer drug, Keytruda. More »
By Lisa Rapaport(Reuters Health) – People who take popular heartburn pills known as proton pump inhibitors (PPIs) may be more likely to develop intes More »
Europe’s leading association of oncologists has thrown its weight behind cheaper copycat versions of biotech cancer drugs that have lost patent protection, saying they are effective and affordable. More »
Logos of Japanese Takeda Pharmaceutical Co are seen at an office building in Glattbrugg near Zurich March 7, 2012. REUTERS/Arnd Wiegmann/File Photo – RTX2RH16 Japan’s Takeda Pharmaceutical Co (4502.T) flagged its appetite for fresh acquisitions to bolster its ... More »
An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith Regeneron Pharmaceuticals Chief Executive Len Schleifer on Monday ripped into Amgen Inc for its insistence on blocking sales of a rival ... More »
The U.S. Food and Drug Administration on Monday approved Egalet Corp’s long-acting opioid painkiller, Arymo ER, and will allow the company to claim it deters abuse by those seeking to dissolve and inject it. More »
Kite Pharma Inc said on Monday it partnered with Daiichi Sankyo Co Ltd to develop and commercialize its cancer treatment therapy in Japan, putting the U.S. company in line to receive up to $250 million in payments. More »
By Andrew M. Seaman(Reuters Health) – Drugs recently approved around the world to fight cancer increased patients’ overall survival, but benefits va More »
A person holds pharmaceutical tablets and capsules in this picture illustration taken in Ljubljana September 18, 2013. REUTERS/Srdjan Zivulovic Last year turned out to be a disappointing one for new drug approvals with the U.S. Food and Drug Administration cle... More »
A woman talks on a mobile phone as she walks past the closed research facility of Semler Research Centre in Bengaluru, India, October 13, 2016. REUTERS/Abhishek N. Chinnappa Vasudeva Prakash left his job as a mechanic in Hyderabad three years ago for what he c... More »
Anthera Pharmaceuticals Inc said on Tuesday that its drug to treat certain cystic fibrosis patients failed a late-stage study, sending the company’s shares tumbling nearly 70 percent in after-hours trading. More »
An artificial leaf designed by scientists at Eindhoven University of Technology, Netherlands December 16, 2016. REUTERS/Jim Drury Dutch scientists have developed an artificial leaf that can act as a mini-factory for producing drugs, an advance that could allow... More »
Two U.S. lawmakers are questioning whether Heritage Pharmaceuticals misled them in response to a 2014 congressional inquiry about the rising price a common antibiotic, after 20 U.S. states this week accused the company of price fixing. More »
Hungarian pharmaceuticals firm Richter has withdrawn its marketing application for one of its biosimilar drugs from the European Medicines Agency in anticipation of a possible negative assessment, the company said on Monday. More »
German biotech firm Medigene said it is drawing more interest from prospective alliance partners for its technology to boost the immune response to cancer after its deal with U.S. peer Bluebird Bio. More »
Short seller Citron Research’s Andrew Left has turned his sights on Express Scripts Holding Co, calling the pharmacy benefit manager (PBM) the “culprit behind pharmaceutical price gouging.” More »
By Gene Emery(Reuters Health) – Two of the largest suppliers of the life-saving drug naloxone have dramatically increased their prices in recent year More »
A screen displays trading information for stocks- Pfizer, Abbott Laboratories, Merck and Company and Eli Lilly and Company on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., May 16, 2016. REUTERS/Brendan McDermid/File Photo Two leading ... More »
A woman looks at a Center for Disease Control (CDC) health advisory sign about the dangers of the Zika virus as she lines up for a security screening at Miami International Airport in Miami, Florida, U.S., May 23, 2016. REUTERS/Carlo Allegri Texas health offic... More »
Four capules of Tamiflu are pictured on a Tamiflu box in Burbank, California, January 31, 2013. REUTERS/Fred Prouser The first generic copy of Roche’s top-selling flu pill Tamiflu hit the U.S. market on Monday, marking a further step in the Swiss drugmaker’s e... More »
The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel, Switzerland October 22, 2013. REUTERS/Arnd Wiegmann/File Photo Swiss drugmaker Novartis’s bid to bolster its eye drug portfolio suffered a setback on Monday when it announced combining ... More »
A logo is pictured on the laboratory building on the Lonza site in Visp, western Switzerland September 10, 2013. REUTERS/Denis Balibouse Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR &... More »
A promising but risky new group of customized cancer drugs will be in focus this weekend at the annual meeting of the American Society of Hematology (ASH), where clinical trial results will help clarify their potential for doctors and investors. More »
A Novartis logo is pictured on its headquarters building in Mumbai April 1, 2013. REUTERS/Vivek Prakash/File Photo An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form of blood cancer in 82 percent of children and young a... More »
A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed U.S regulators said on Friday they would allow Eli Lilly and Co to state that its diabetes drug Jardiance reduces risk of death... More »
A person holds pharmaceutical tablets and capsules in this picture illustration taken in Ljubljana September 18, 2013. REUTERS/Srdjan Zivulovic U.S. health spending in 2015 rose at its fastest rate since 2007, driven by expanded access to insurance under the A... More »
Scientist Frantisek Lizal looks at a model of a functioning human lung that can be used to simulate chronic diseases and their treatments in the Brno University of Technology in Brno, Czech Republic, November 22, 2016. Picture taken November 22, 2016. REUTERS/... More »
A man crosses a main road as pedestrians carrying food walk along the footpath in central Sydney, Australia, August 12, 2015. REUTERS/David Gray/File Photo – Scientists studying yo-yo dieting in mice say the tendency for people to regain excess weight rapidly ... More »
A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel February 17, 2015. REUTERS/Arnd Wiegmann U.S. healthcare company Johnson & Johnson (JNJ.N) said on Friday it was in preliminary talks with Actelion (ATLN.S) about a potentia... More »
India has reported an outbreak of a highly contagious bird flu virus in the southwestern state of Karnataka, the World Organisation for Animal Health (OIE) said on Friday, citing a report from the Indian agriculture ministry. More »
Herve Brailly, CEO of Innate Pharma, attends the Reuters Biotech summit in Paris June 3, 2009. REUTERS/John Schults France’s Innate Pharma believes that its cash position and portfolio are sufficiently robust for the cancer drug company to remain independent f... More »
An online game following the journey of an elderly former sea explorer who has lost his memories has helped scientists lead a vast international dementia study and given important preliminary results about human orientation skills. More »
The Google logo adorns the entrance of Google Germany headquarters in Hamburg, Germany July 11, 2016. Picture taken July 11, 2016. REUTERS/Morris Mac Matzen Novartis has abandoned a 2016 goal to start testing its autofocus contact lens on people, though it sai... More »
A woman stands near a poster explaining about the Zika virus at the Ministry of Health office in Jakarta, Indonesia September 2, 2016. REUTERS/Iqro Rinaldi/File Photo The World Health Organization on Friday declared that Zika no longer constitutes an internati... More »
Signage for GlaxoSmithKline is seen on it’s offices in London, Britain, March 30, 2016. REUTERS/Toby Melville/File Photo GlaxoSmithKline said on Monday it had filed its new three-in-one inhaled lung drug for U.S. approval, putting it on track to reach the mark... More »
A company logo is seen at a Pfizer office in Dublin, Ireland November 24, 2015. REUTERS/Cathal McNaughton Pfizer Inc’s Celebrex arthritis drug was shown to be at least as safe as the widely used prescription-strength versions of painkillers ibuprofen and napro... More »
Taking medicines to lower blood pressure and cholesterol failed to prevent cognitive and functional declines in older adults with moderate risk of heart disease, according to results of a clinical trial presented on Sunday. More »
Signage for GlaxoSmithKline is seen on it’s offices in London, Britain, March 30, 2016. REUTERS/Toby Melville/File Photo The world’s top drugmakers have improved access to medicines in developing countries but still need to do more to make a wider range of pro... More »
A Novartis logo is pictured on its headquarters building in Mumbai April 1, 2013. REUTERS/Vivek Prakash/File Photo Novartis’s investigational drug PKC 412 won U.S. Food and Drug Administration priority review, the Swiss drugmaker said on Monday, keeping up mom... More »
Richter received a positive opinion from European regulators recommending that its generic osteoporosis drug Terrosa be granted marketing authorization, the Hungarian drug maker said in a statement on Monday. More »
Corbus Pharmaceuticals Holdings Inc said its lead drug outperformed a placebo in a mid-stage study involving patients with a form of systemic sclerosis, an incurable autoimmune condition caused by abnormal growth of connective tissue. More »
A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo Dynavax Technologies Corp said on Monday the U.S. Food and Drug Administration had rejected the marketing applicatio... More »
Roche tablets are seen in this photo illustration shot January 18, 2016. REUTERS/Dado Ruvic/File Photo The spotlight on finding a cancer cure has spurred improvements in systems to collect and analyze oncology data, but efforts to track patients with other dis... More »
Scientists at Stanford University School of Medicine have used the CRISPR gene editing tool to repair the gene that causes sickle cell disease in stem cells from diseased patients, paving the way for a potential cure for the disease, which affects up to 5 mill... More »
A nurse takes the temperature of a patient showing chikungunya-like fever symptoms at a health centre in Villa San Francisco on the outskirts of Tegucigalpa October 2, 2014. REUTERS/Jorge Cabrera By Magdalena MisLONDON (Thomson Reuters Foundation) – “Lazy mosq... More »
A person holds pharmaceutical tablets and capsules in this picture illustration taken in Ljubljana September 18, 2013. REUTERS/Srdjan Zivulovic By Magdalena MisLONDON (Thomson Reuters Foundation) – Essential medicines could be provided for as little as $1-$2 a... More »
By Kathryn Doyle(Reuters Health) – For patients with advanced cancer, palliative care should start early and be an integral part of treatment, not ju More »
Roche tablets are seen in this photo illustration shot in Zenica, Bosnia and Herzegovina, January 18, 2016. REUTERS/Dado Ruvic/File Photo Four patients have suffered serious adverse events in a clinical trial of an experimental hemophilia medicine from Roche, ... More »
Cancer drugmakers are cutting prices to ensure their medicines are used routinely on Britain’s National Health Service, following the overhaul of a cancer drug funding scheme, with Japan’s Eisai the latest to win approval. More »
Health insurer Cigna Corp has discontinued its policy of requiring doctors to seek authorization before treating opioid addicts, as part of a fight against an epidemic of opioid abuse, New York Attorney General Eric Schneiderman said on Friday. More »
U.S. Democratic presidential nominee Hillary Clinton listens as U.S. Senator Bernie Sanders speaks about college affordability during a campaign event at the University of New Hampshire in Durham, New Hampshire, United States September 28, 2016. REUTERS/Brian ... More »
Signage for GlaxoSmithKline is seen on it’s offices in London, Britain, March 30, 2016. REUTERS/Toby Melville/File Photo GlaxoSmithKline said on Monday it had filed its shingles vaccine Shingrix for U.S. regulatory approval, bringing the potential blockbuster ... More »
Drugmaker Intercept Pharmaceuticals Inc’s drug to treat a rare liver condition was conditionally approved an advisory committee to the European Medicines Agency on Friday. More »
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014. REUTERS/Brendan McDermid AbbVie Inc won the conditional backing of an advisory committee of the European Medicines Agency (EMA) on Frid... More »
Scientists launched a global initiative on Friday to map out and describe every cell in the human body in a vast atlas that could transform researchers’ understanding of human development and disease. More »
Yoshinori Ohsumi, a professor of Tokyo Institute of Technology, attends a news conference after he won the Nobel medicine prize at Tokyo Institute of Technology in Tokyo, Japan, October 3, 2016. REUTERS/Kim Kyung-Hooni Japan’s Yoshinori Ohsumi won the 2016 Nob... More »
J. Fraser Stoddart, one of the winners of 2016 Nobel Prize for Chemistry, raises his glass for a toast at Northwestern University in the Chicago suburb of Evanston, Illinois, U.S., October 5, 2016. REUTERS/Jim Young A trio of European scientists has won the 20... More »
By Andrew M. Seaman(Reuters Health) – People with terminal illnesses may legally end their lives with certain medications in the U.S. state of Washi More »
By Andrew M. Seaman(Reuters Health) – Common blood pressure medications may increase the risk for severe mood disorder episodes, a new study suggest More »
A San Francisco-based hedge fund has filed a lawsuit against Theranos Inc, accusing the blood testing company of using fraudulent methods to attract an investment of nearly $100 million, according to an investor letter filed by the fund. More »
A trader passes by a screen displaying the tickers symbol for Bristol-Myers Squibb on the floor at the New York Stock Exchange, April 25, 2013. REUTERS/Brendan McDermid New data is likely to prompt doctors to abandon Bristol-Myers Squibb’s immunotherapy Opdivo... More »
Scientists in Britain have found a new link between the diversity of bacteria in human poo – the human fecal microbiome – and levels of harmful types of body fat. More »
A court ruled in Depomed Inc’s favor in a patent dispute over its opioid drug, Nucynta, a decision that could help pave the way for the drug maker to explore a sale. More »
The U.S. Food and Drug Administration warned against the use of homeopathic teething tablets and gels on Friday, citing potential risks to infants and children and prompting CVS Health Corp Inc to withdraw the products. More »
The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel, Switzerland October 22, 2013. REUTERS/Arnd Wiegmann/File Photo Novartis’s psoriasis drug Cosentyx showed long-term efficacy in keeping patients’ skin clear, the Swiss drugmaker said on ... More »
The logo of healthcare company Johnson & Johnson is seen in front of an office building in Zug, Switzerland July 20, 2016. REUTERS/Arnd Wiegmann An experimental biotech drug developed by Johnson & Johnson proved more effective at clearing moderate to severe ca... More »
German biotech Morphosys moved a step closer to getting its first antibody drug onto the market as its licensee, Johnson & Johnson unit Jenssen, reported positive results from a phase 3 study of psoriasis drug guselkumab. More »
Big pharmaceutical companies are waging courtroom patent battles against each other over biosimilars, as the line blurs between companies known for their inn More »
An Amgen sign is seen at the company’s office in South San Francisco, California in this October 21, 2013 file photo. REUTERS/Robert Galbraith/Files The line dividing makers of brand-name drugs and copycat medicines is blurring as companies known for innovativ... More »
An airplane carrying a banner asking people to use insect repellent to avoid the Zika virus, flies over Miami, Florida, U.S., September 13, 2016. REUTERS/Carlo Allegri The unprecedented aerial spraying of products that kill both adult mosquitoes as well as the... More »
Endo International Plc (ENDP.O) said Chief Executive Rajiv De Silva had stepped down and would be replaced by generics division head Paul Campanelli, as the drugmaker grapples with a large debt load and mounting pressure on some of its drug prices. More »
The U.S. Food and Drug Administration on Friday approved Amgen Inc’s biosimilar version of AbbVie’s top-selling arthritis drug, Humira. More »
French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo French drugmaker Sanofi (SASY.PA) and its U.S. partner Regeneron Pharmaceuticals (REGN.O) could win U.S. ap... More »
The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S., August 1, 2016. REUTERS/Andrew Kelly U.S. drugmaker Pfizer Inc said on Monday it had decided not to separate into two publicly traded companies at this time. More »
An experimental stem cell therapy developed by Asterias Biotherapeutics restored some movement to patients paralyzed by recent spinal cord injuries, according to interim data from a small study being presented on Wednesday. More »
A sign for the headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec June 14, 2016. REUTERS/Christinne Muschi Valeant Pharmaceuticals International Inc said its discount and rebates program for two high-priced heart drugs would cov... More »
Aedes aegypti mosquitoes are seen at the Laboratory of Entomology and Ecology of the Dengue Branch of the U.S. Centers for Disease Control and Prevention in San Juan, Puerto Rico, March 6, 2016. REUTERS/Alvin Baez/File Photo State officials in Florida on Frida... More »
A Novartis logo is pictured on its headquarters building in Mumbai April 1, 2013. REUTERS/Vivek Prakash/File Photo Novartis’s investigational multiple sclerosis drug cut the risk of disability progression in patients with a tough-to-treat form of the disease v... More »
A Novartis logo is pictured on its headquarters building in Mumbai April 1, 2013. REUTERS/Vivek Prakash/File Photo Novartis on Monday intensified its bid to convince doctors to prescribe its heart failure drug Entresto, releasing an analysis that concluded the... More »
Aedes aegypti mosquitoes are seen at the Laboratory of Entomology and Ecology of the Dengue Branch of the U.S. Centers for Disease Control and Prevention in San Juan, Puerto Rico, March 6, 2016. REUTERS/Alvin Baez/File Photo It began with what felt like a punc... More »
The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor/File Photo GlaxoSmithKline is to sell its portfolio of anesthetic drugs to South Africa’s Aspen Pharmacare for up to 280 million pounds ($372 million) as pa... More »
Swiss biotechnology firm ADIENNE said on Monday it plans to seek a listing on Switzerland’s bourse in an initial public offering. More »
A resident shields his nose as pest control officer carry out fogging in the Aljunied Crescent cluster in Singapore, September 3, 2016 in this photo taken by Antara Foto. Antara Foto/MN Kanwa/via REUTERS Singapore authorities on Sunday confirmed 27 more cases ... More »
Malaysia is bracing for more Zika cases, officials said on Sunday, after detecting the first locally infected patient, which could further stretch a health system struggling with dengue, another mosquito-borne virus that can be fatal. More »
A worker fogs the drains in the common areas of a public housing estate at an area where locally transmitted Zika cases were discovered in Singapore August 31, 2016. REUTERS/Edgar Su Singapore confirmed 26 more cases of locally transmitted Zika infections, the... More »
A 61-year-old man diagnosed with the first case of a locally transmitted Zika infection in Malaysia has died from heart disease complications, and not from the mosquito-borne virus, the health ministry said on Saturday. More »
The U.S. Food and Drug Administration on Friday banned some over-the-counter antibacterial hand and body wash products, saying they are no more effective than soap and water and could cause long-term harm. More »
FILE PHOTO — U.S. Democratic presidential nominee Hillary Clinton speaks at Futuramic Tool & Engineering in Warren, Michigan August 11, 2016. REUTERS/Chris Keane/File Photo Hillary Clinton said on Friday that if elected to the White House she would create an o... More »
Swiss drugmaker Roche’s logo is seen at their headquarters in Basel, Switzerland January 28, 2016. REUTERS/Arnd Wiegmann Swiss drugmaker Roche (ROG.S) said on Monday the U.S. Food and Drug Administration (FDA) had issued an Emergency Use Authorization (EUA) fo... More »
